n(6)-2-(4-amino-3-iodophenyl)ethyladenosine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 1 studies
Studies (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Trials (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Recent Studies (post-2010) (n(6)-2-(4-amino-3-iodophenyl)ethyladenosine) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
---|---|---|---|---|---|
6 | 0 | 0 | 1,333 | 4 | 133 |
Protein | Taxonomy | n(6)-2-(4-amino-3-iodophenyl)ethyladenosine (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourgoin, S; Cesselin, F; Hamon, M; Mauborgne, A; PoliƩnor, H | 1 |
1 other study(ies) available for n(6)-2-(4-amino-3-iodophenyl)ethyladenosine and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neuropeptides; Pain; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Spinal Cord; Substance P; Xanthines | 2002 |